Tissue engineering of heart valves;Tissue Engneeringvon Herzklappen

Chirurg

Volumn 82, Issue 4, 2011, Pages 311-318

  Akhyari, P ^a   Minol, P ^a   Assmann, A ^a   Barth, M ^b   Kamiya, H ^a   Lichtenberg, A ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cardiac surgery; Decellularization; Heart valves; Regeneration; Tissue engineering

Indexed keywords

TISSUE SCAFFOLD;

BIOPROSTHESIS; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; METHODOLOGY; PROSTHESIS; REVIEW; TISSUE ENGINEERING; TISSUE REGENERATION; VALVULAR HEART DISEASE;

BIOPROSTHESIS; GUIDED TISSUE REGENERATION; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PROSTHESIS DESIGN; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 79953326300     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-010-2031-2     Document Type: Article

References (37)

1. Tweddell JS, Pelech AN, Jaquiss RD et al (2005) Aortic valve repair. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 112-121.
2. El-Ahdab F, Benjamin DK Jr, Wang A et al (2005) Risk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremia. Am J Med 118: 225-229.
3. Chikwe J, Filsoufi F, Carpentier AF (2010) Prosthetic valve selection for middle-aged patients with aortic stenosis. Nat Rev Cardiol 7: 711-719.
4. Golczyk K, Kompis M, Englberger L et al (2010) Heart valve sound of various mechanical composite grafts, and the impact on patients' quality of life. J Heart Valve Dis 19: 228-232.
5. Vesely I (2005) Heart valve tissue engineering. Circ Res 97: 743-755.
6. Brown JW, Ruzmetov M, Fukui T et al (2006) Fate of the autograft and homograft following Ross aortic valve replacement: reoperative frequency, outcome, and management. J Heart Valve Dis 15: 253-260.
7. Schenke-Layland K, Opitz F, Gross M et al (2003) Complete dynamic repopulation of decellularized heart valves by application of defined physical signals - an in vitro study. Cardiovasc Res 60: 497-509.
8. Lichtenberg A, Cebotari S, Tudorache I et al (2006) Flow-dependent re-endothelialization of tissue-engineered heart valves. J Heart Valve Dis 15: 287-293.
9. Akhyari P, Kamiya H, Gwanmesia P et al (2010) In vivo functional performance and structural maturation of decellularised allogenic aortic valves in the subcoronary position. Eur J Cardiothorac Surg 38: 539-546.
10. Cebotari S, Walles T, Sorrentino S et al (2002) Guided tissue regeneration of vascular grafts in the peritoneal cavity. Circ Res 90: e71.
11. McIntire L, Greisler H, Griffith L et al (2002) WETC panel report on tissue engineering research. International Technology Research Institute, January 2002, Baltimore, MD.
12. Steinhoff G, Stock U, Karim N et al (2000) Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation 102: III50-55.
13. Schmidt CE, Baier JM (2000) Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials 21: 2215-2231.
14. Knight RL, Booth C, Wilcox HE et al (2005) Tissue engineering of cardiac valves: re-seeding of acellular porcine aortic valve matrices with human mesenchymal progenitor cells. J Heart Valve Dis 14: 806-813.
15. Cebotari S, Lichtenberg A, Tudorache I et al (2006) Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation 114: 132-137.
16. Weston MW, Yoganathan AP (2001) Biosynthetic activity in heart valve leaflets in response to in vitro flow environments. Ann Biomed Eng 29: 752-763.
17. Engelmayr GC Jr, Rabkin E, Sutherland FW et al (2005) The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue. Biomaterials 26: 175-187.
18. Hoerstrup SP, Sodian R, Daebritz S et al (2000) Functional living trileaflet heart valves grown in vitro. Circulation 102: 44-49.
19. Teebken OE, Wilhelmi M, Haverich A (2005) Tissue engineering for heart valves and vascular grafts. Chirurg 76: 453-466.
20. Flanagan TC, Pandit A (2003) Living artificial heart valve alternatives: a review. Eur Cell Mater 6: 28-45.
21. Wang Q, McGoron AJ, Bianco R et al (2010) In-vivo assessment of a novel polymer (SIBS) trileaflet heart valve. J Heart Valve Dis 19: 499-505.
22. Rashid ST, Salacinski HJ, Hamilton G, Seifalian AM (2004) The use of animal models in developing the discipline of cardiovascular tissue engineering: a review. Biomaterials 25: 1627-1637.
23. Kasimir MT, Rieder E, Seebacher G et al (2003) Comparison of different decellularization procedures of porcine heart valves. Int J Artif Organs 26: 421-427.
24. Tudorache I, Cebotari S, Sturz G et al (2007) Tissue engineering of heart valves: biomechanical and morphological properties of decellularized heart valves. J Heart Valve Dis 16: 567-574.
25. Korossis SA, Booth C, Wilcox HE et al (2002) Tissue engineering of cardiac valve prostheses II: biomechanical characterization of decellularized porcine aortic heart valves. J Heart Valve Dis 11: 463-471
26. da Costa FD, Costa AC, Prestes R et al (2010) The early and midterm function of decellularized aortic valve allografts. Ann Thorac Surg 90: 1854-1860.
27. Simon P, Kasimir MT, Seebacher G et al (2003) Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg 23: 1002-1006.
28. Naso F, Gandaglia A, Iop L et al (2010) First quantitative assay of alpha-Gal in soft tissues: presence and distribution of the epitope before and after cell removal from xenogeneic heart valves. Acta Biomater (in press).
29. Lichtenberg A, Breymann T, Cebotari S, Haverich A (2011) Cell seeded tissue engineered cardiac valves based on allograft and xenograft scaffolds. Prog Pediatr Cardiol (in press).
30. Leyh RG, Wilhelmi M, Walles T et al (2003) Acellularized porcine heart valve scaffolds for heart valve tissue engineering and the risk of cross-species transmission of porcine endogenous retrovirus. J Thorac Cardiovasc Surg 126: 1000-1004.
31. Lehr EJ, Rayat GR, Chiu B et al (2010) Decellularization reduces immunogenicity of sheep pulmonary artery vascular patches. J Thorac Cardiovasc Surg (in press).
32. Wu DC, Boyd AS, Wood KJ (2008) Embryonic stem cells and their differentiated derivatives have a fragile immune privilege but still represent novel targets of immune attack. Stem Cells 26: 1939-1950.
33. Lengner CJ (2010) iPS cell technology in regenerative medicine. Ann N Y Acad Sci 1192: 38-44.
34. Goldstein S, Clarke DR, Walsh SP et al (2000) Transpecies heart valve transplant: advanced studies of a bioengineered xeno-autograft. Ann Thorac Surg 70: 1962-1969.
35. Baraki H, Tudorache I, Braun M et al (2009) Orthotopic replacement of the aortic valve with decellularized allograft in a sheep model. Biomaterials 30: 6240-6246.
36. Lichtenberg A, Tudorache I, Cebotari S et al (2006) Preclinical testing of tissue-engineered heart valves re-endothelialized under simulated physiological conditions. Circulation 114: I559-565.
37. Lichtenberg A, Tudorachea I, Cebotaria S et al (2006) In vitro re-endothelialization of detergent decellularized heart valves under simulated physiological dynamic conditions. Biomaterials 27: 4221-4229.